Digital Regulators open the AI floodgates in life sciences In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.
Sales & Marketing Sponsored Beyond the grid: Rethinking tracking studies for pharma’s ne... As the healthcare landscape continues to evolve rapidly, the tools used to understand it must keep pace.
Digital Sponsored What does it mean to have an AI-first mindset in pharma? The importance of AI in pharma and life sciences cannot be overstated.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
R&D Post-hype, pre-value: The real AI-pharma shift starts now The first era of AI in pharma was built on potential. This next era will be built on proof, reinforcing even greater potential.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
News CEPI steps in to fund Moderna's pandemic flu jab Thanks to CEPI, Moderna's H5 bird flu vaccine can start a pivotal trial shelved after funding for the jab was pulled in the US by HHS Sec Kennedy.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
